Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia

Brain

Volumn 129, Issue 11, 2006, Pages 3051-3065

  Le Ber, Isabelle ^a   Guedj, Eric ^c   Gabelle, Audrey ^a   Verpillat, Patrice ^a   Volteau, Magali ^a   Thomas Anterion, Catherine ^e   Decousus, Marielle ^k   Hannequin, Didier ^f   Véra, Pierre ^g   Lacomblez, Lucette ^a,b   Camuzat, Agnès ^a   Didic, Mira ^c   Puel, Michèle ^h   Lotterie, Jean Albert ⁱ   Golfier, Véronique ^j   Bernard, Anne Marie ^k   Vercelletto, Martine ^l   Magne, Christine ^m   Sellal, François ⁿ   Namer, Izzie ^o   Michel, Bernard François ^l   Pasquier, Jacques ^m   Salachas, François ^a,e   Bochet, Jean ⁿ   Brice, Alexis ^a,d,o   Habert, Marie Odile ^p   Dubois, Bruno ^a,d   more..

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c TIMONE HOSPITAL   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

^e SERVICE DE NEUROLOGIE   (France)

^f ROUEN UNIVERSITY HOSPITAL   (France)

^g CENTRE HENRI BECQUEREL   (France)

^h CHU PURPAN   (France)

ⁱ CHU RANGUEIL   (France)

^j Centre Hospitalier de Saint Brieuc   (France)

^k CENTRE EUGÈNE MARQUIS   (France)

^l NANTES UNIVERSITY HOSPITAL   (France)

^m CHU de Nantes   (France)

ⁿ UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^o HÔPITAL DE HAUTEPIERRE   (France)

^p Service de Médecine Interne   (France)

more..

Author keywords

Frontotemporal dementia; Frontotemporal lobar degeneration; fvFTD; MAPT gene; SPECT; SPM

Indexed keywords

TECHNETIUM 99M;

ADULT; AFFECT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BEHAVIOR; BRAIN PERFUSION; BRAIN STEM; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEMOGRAPHY; EMOTION; FAMILY HISTORY; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; PERFUSION; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL;

ADULT; AGE OF ONSET; AGED; BRAIN; BRAIN MAPPING; BRAIN STEM; CEREBROVASCULAR CIRCULATION; CROSS-SECTIONAL STUDIES; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; SOCIAL BEHAVIOR DISORDERS; SURVIVAL ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33750601024     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl288     Document Type: Article

References (94)

1. Adam S, Van der Linden M, Poitrenaud J, Kalafat M, et les membres du GREMEM (2004) Lépreuve de rappel indicé à 48 items (RI-48). In: Van der Linden M, Adam S, Agniel A, Baisset Mouly C (eds) Lévaluation des troubles de la mémoire: Présentation de quatres tests de mémoire épisodique (avec leur étalonnage). Marseille: Solal.
2. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916-9.
3. Barrash J, Tranel D, Anderson SW. Acquired personality disturbances associated with bilateral damage to the ventromedial prefrontal region. Dev Neuropsychol 2000; 18: 355-81.
4. Benoit M, Dygai I, Migneco O, Robert PH, Bertogliati C, Darcourt J, et al. Behavioral and psychological symptoms in Alzheimer's disease. Relation between apathy and regional cerebral perfusion. Dement Geriatr Cogn Disord 1999; 10: 511-7.
5. Bonte FJ, Harris TS, Roney CA, Hynan LS. Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign. J Nucl Med 2004; 45: 771-4.
6. Borroni B, Yancopoulou D, Tsutsui M, Padovani A, Sawcer SJ, Hodges JR, et al. Association between tau H2 haplotype and age at onset in frontotemporal dementia. Arch Neurol 2005; 62: 1419-22.
7. Bozeat S, Gregory CA, Lambon RMA, Hodges JR. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry 2000; 69: 178-86.
8. Broe M, Hodges JR, Schofield E, Sheperd CE, Kril JJ, Halliday GM. Staging disease severity in pathologically confirmed cases of frontotemporal dementia. Neurology 2003; 60: 1005-11.
9. Brun A. Frontal lobe degeneration of non-Alzheimer type I. Neuropathology. Arch Gerontol Geriatr 1987; 6: 193-208.
10. Cairns NJ, Perry RH, Jaros E, Burn D, McKeith IG, Lowe JS, et al. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 2003; 341: 3177-80.
11. Cairns NJ, Grossman M, Arnold SE, Burn DJ, Jaros E, Perry RH, et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004; 63: 1376-84.
12. Chow TW, Miller B, Hayashi V, Geschwind DH. Inheritance of frontotemporal dementia. Arch Neurol 1999; 56: 817-22.
13. Craig AH, Cummings JL, Fairbanks L, Itti L, Miller BL, Li J, et al. Cerebral blood flow correlates of apathy in Alzheimer disease. Arch Neurol 1996; 53: 1116-20.
14. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 2006; 442: 920-4.
15. Cummings JL, Duchen LW. Kluver-Bucy syndrome in Pick disease: clinical and pathologic correlations. Neurology 1981; 31: 1415-22.
16. Didic M, Guisiano B, De Laforte C, Ceccaldi M, Poncet M. Identification of clinical subtypes of fronto-temporal dementia and cerebral blood flow on SPECT: preliminary results. Alzheimers Rep 1998; 1: 179-85.
17. Diehl-Schmid J, Grimmer T, Drzezga A, Bornschein S, Riemenschneider M, Forstl H, et al. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Dement Geriatr Cogn Disord 2006; 22: 346-51.
18. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology 2000; 55: 1621-6.
19. Eslinger PJ, Damasio AR. Severe disturbance of higher cognition after bilateral frontal lobe ablation: patient EVR. Neurology 1985; 35: 1731-41.
20. Folstein MF, Folstein SE, Mc Hugh PR. "Mini Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
21. Forman MS, Farmer J, Johnson JK, Clark CM, Arnold SE, Coslett HB, et al. Frontotemporal dementia: clinicopathological correlations. Ann Neurol 2006; 59: 952-62.
22. Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet, 2006; 15: 2988-3001.
23. Godbolt AK, Josephs KA, Revesz T, Warrington EK, Lantos P, King A. Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration. Arch Neurol 2005; 62: 1097-101.
24. Gustafson L. Clinical picture of frontotemporal lobar degeneration of non Alzheimer type. Dementia 1993; 4: 143-8.
25. Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frolich L, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 2002; 17: 302-16.
26. Hodges JR. Frontotemporal dementia (Pick's disease): clinical features and assessment. Neurology 2001; 56: S6-10.
27. Hodges JR, Patterson K. Nonfluent progressive aphasia and semantic dementia: a comparative neuropsychological study. J Int Neuropsychol Soc 1996; 2: 511-24.
28. Hodges JR, Patterson K, Oxbury S, Funnell E. Semantic dementia: progressive fluent aphasia with temporal lobe atrophy. Brain 1992; 115: 1783-806.
29. Hodges JR, Patterson K, Ward R, Garrard P, Bak T, Perry R, et al. The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study. Neuropsychologia 1999; 13: 31-40.
30. Hodges JR, Davies RR, Xuereb JH, Kril J, Halliday G. Survival in frontotemporal dementia. Neurology 2003; 61: 349-54.
31. Hodges JR, Davies RR, Xuereb JH, Casey B, Broe M, Bak TH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004; 56: 399-406.
32. Hooten WM, Lyketsos CG. Frontotemporal dementia: a clinicopathological review of four post-mortem studies. J Neuropsychiatry Clin Neurosci 1996; 8: 10-9.
33. Hornak J, Bramham J, Rolls ET, Morris RG, O'Doherty J, Bullock PR, et al. Changes in emotion after circumscribed surgical lesions of the orbitofrontal and cingulate cortices. Brain 2003; 126: 1691-712.
34. Hsu KS, Huang CC, Liang YC, Wu HM, Chen YL, Lo SW, et al. Alterations in the balance of protein kinase and phosphatase activities and age-related impairments of synaptic transmission and long-term potentiation. Hippocampus 2002; 12: 787-802.
35. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5′-splice site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702-5.
36. Ikeda A, Brown J, Holland AJ, Fukuhara R, Hodges JR. Changes in appetite, food preference and eating habits in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 73: 371-6.
37. Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med 1998; 39: 1875-8.
38. Jeong Y, Cho SS, Park JM, Kang SJ, Lee JS, Kang E, et al. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med 2005; 46: 233-9.
39. Johnson JK, Diehl J, Mendez MF, Neuhas J, Shapira JS, Forman M, et al. Frontotemporal lobar degeneration, demographic characteristics of 353 patients. Arch Neurol 2005; 62: 925-30.
40. Josephs KA, Petersen RC, Knopman DS, Boeve BF, Whitwell JL, Duffy JR, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 2006; 66: 41-8.
41. Kamo H, McGeer PL, Harrop R, McGeer EG, Calne DB, Martin WR, et al. Positron emission tomography and histopathology in Pick's disease. Neurology 1987; 37: 439-45.
42. Kertesz A. Pick complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. Neurologist 2003; 9: 311-7.
43. Kertesz A, Davidson W, McCabe P, Munoz D. Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia. Alzheimer Dis Assoc Disord 2003; 17: 223-9.
44. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain 2005; 128: 1996-2005.
45. Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ, et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 2005; 57: 480-8.
46. Kril JJ, Halliday GM. Clinicopathological staging of frontotemporal dementia severity: correlation with regional atrophy. Dement Geriatr Cogn Disord 2004; 17: 311-5.
47. Lang AE, Riley DE, Bergeron C. Cortical-basal ganglionic degeneration. In: Calne DB, editor. Neurodegenerative diseases. Philadelphia: W.B. Saunders; 1994. p. 877-94.
48. Le Rhun E, Richard F, Pasquier F. Natural history of primary progressive aphasia. Neurology 2005; 65: 887-91.
49. Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006; 16: 916-28.
50. Lindau M, Almkvist O, Kushi J, Boone K, Johansson SE, Wahlund LO, et al. First symptoms-frontotemporal dementia versus Alzheimer's disease. Dement Geriatr Cogn Disord 2000; 11: 286-93.
51. Lipton AM, White CL III, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol (Berl) 2004; 108: 379-85.
52. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1-9.
53. Mattis S. Dementia rating scale. Odessa, FL: Psychological Assessment Resources; 1988.
54. McKeith IG, Perry EG, Perry RH. Report of the second dementia with Lewy body international workshop. Neurology 1999; 53: 902-5.
55. McKhann GM, Albert M, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia. Arch Neurol 2001; 58: 1803-9.
56. McMurtray AM, Chen AK, Shapira JS, Chow TW, Mishkin F, Miller BL, et al. Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia. Neurology 2006; 66: 517-22.
57. Mendez MF, Shapira JS, Miller BL. Stereotypical movements and frontotemporal dementia. Mov Disord 2005; 20: 742-5.
58. Mesulam M. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982; 11: 592-8.
59. Migneco O, Benoit M, Koulibaly PM, Dygai I, Bertogliati C, Desvignes P, et al. Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: a study in Alzheimer's disease and nondemented patients. Neuroimage 2001; 13: 896-902.
60. Miller BL, Cumming JL, Villanueva-Meyer J, Boone K, Mehringer CM, Lesser IM, et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 1991; 41: 1374-82.
61. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-54.
62. Neary D, Snowden JS, Mann DM. Frontotemporal dementia. Lancet Neurol 2005; 4: 771-80.
63. Nelson HE. A modified card sorting test sensitive to frontal lobe defect. Cortex 1976; 12: 313-24.
64. Nyatsanza S, Shetty T, Gregory C, Lough S, Dawson K, Hodges JR. A study of stereotypic behaviours in Alzheimers's disease and frontal and temporal variant frontotemporal dementia. J Neurol Neurosurg Psychiatry 2003; 74: 1398-402.
65. Nguyen DK, Botez MI. Diaschisis and neurobehavior. Can J Neurol Sci 1998; 25: 5-12.
66. Piguet O, Brooks WS, Halliday GM, Schofield PR, Stanford PM, Kwok JB, et al. Similar early clinical presentations in familial and nonfamilial frontotemporal dementia. J Neurol Neurosurg Psychiatry 2004; 75: 1743-5.
67. Rascovsky K, Salmon DP, Lipton AM, Leverenz JB, De Carli C, Jagust WJ, et al. Rate of progression differs in frontotemporal dementia and Alzheimer disease. Neurology 2005; 65: 397-403.
68. Rankin KP, Rosen HJ, Kramer JH, Schauer GF, Weiner MW, Schuff N, et al. Right and left medial orbitofrontal volumes show an opposite relationship to agreeableness in FTD. Dement Geriatr Cogn Disord 2004; 17: 328-32.
69. Ratnavalli E, Brayne C, Dawson K, Hodges JR. The prevalence of frontotemporal dementia. Neurology 2002; 58: 1615-21.
70. Roberson ED, Hesse JH, Rose KD, Slama H, Johnson JK, Yaffe K, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 2005; 65: 719-25.
71. Rolls ET. Taste, olfactory, and food texture processing in the brain and the control of food intake. Physiol Behav 2005; 85: 45-56.
72. Rolls ET, Critchley HD, Browning AS, Hernadi I, Lenard L. Responses to the sensory properties of fat of neurons in the primate orbitofrontal cortex. J Neurosci 1999; 19: 1532-40.
73. Rosen HJ, Allison SC, Schauer GF, Gorno-Tempini ML, Weiner MW, Miller BL. Neuroanatomical correlates of behavioural disorders in dementia. Brain 2005; 128: 2612-25.
74. Rosso SM, Donker Kaat L, Baks T, Joosse M, de Koning I, Pijnenburg Y, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 2003; 126: 2016-22.
75. Santens P, De Bleecker J, Goethals P, Strijckmans K, Lemahieu I, Slegers G, et al. Differential regional cerebral uptake of 18F-fluoro-2-deoxy-D-glucose in Alzheimer's disease and frontotemporal dementia at initial diagnosis. Eur Neurol 2001; 45: 19-27.
76. Salmon E, Garraux G, Delbeuck X, Colette F, Kalbe E, Zueudorf G, et al. Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia. Neuroimage 2003; 20: 435-40.
77. Sarazin M, Michon A, Pillon B, Samson Y, Canuto A, Gold G, et al. Metabolic correlates of behavioral and affective disturbances in frontal lobe pathologies. J Neurol 2003; 250: 827-33.
78. Seeley WW, Bauer AM, Miller BL, Gorno-Tempini ML, Kramer JH, Weiner M, et al. The natural history of temporal variant frontotemporal dementia. Neurology 2005; 64: 1384-90.
79. Shi J, Shaw CL, Du Plessis D, Richardson AM, Bailey KL, Julien C, et al. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol (Berl) 2005; 110: 501-12.
80. Shigenobu K, Ikeda M, Fukuhara R, Maki N, Hokoishi K, Nebu A, et al. The Stereotypy Rating Inventory for frontotemporal lobar degeneration. Psychiatry Res 2002; 110: 175-87.
81. Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005; 37: 806-8.
82. Sleegers K, Roks G, Theuns J, Aulchenko YS, Rademakers R, Cruts M, et al. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population. Brain 2004; 127: 1641-9.
83. Snowden JS, Neary D, Mann D, editors. Frontotemporal lobar degeneration: frontotemporal dementia, progressive aphasia, semantic dementia. London: Churchill Livingstone; 1996.
84. Snowden JS, Bathgate D, Varma A, Blackshaw A, Gibbons ZC, Neary D. Distinct behavioural profiles in frontotemporal dementia and semantic dementia. J Neurol Neurosurg Psychiatry 2001; 70: 323-32.
85. Starkstein SE, Migliorelli R, Teson A, Petracca G, Chemerinsky E, Manes F, et al. Specificity of changes in cerebral blood flow in patients with frontal lobe dementia. J Neurol Neurosurg Psychiatry 1994; 57: 790-6.
86. Stevens M, Van Duijn CM, Kamphorst W, de Knijff P, Heutink P, van Gool WA, et al. Familial aggregation in frontotemporal dementia. Neurology 1998; 50: 1541-5.
87. Taniguchi S, Mc Donagh AM, Pickering-Brown SM, Umeda Y, Iwatsubo T, Hasegawa M, et al. The neuropathology of frontotemporal lobar degeneration with respect to the cytological and biochemical characteristics of tau protein. Neuropathol Appl Neurobiol 2004; 30: 1-18.
88. Tekin S, Mega MS, Masterman DM, Chow T, Garakian J, Vinters HV, et al. Orbitofrontal and anterior cingulate cortex neurofibrillary tangle burden is associated with agitation in Alzheimer disease. Ann Neurol 2001; 49: 355-61.
89. The Lund and Manchester Groups. Consensus statement: clinical and neuropathological criteria for fronto-temporal dementia. J Neurol Neurosurg Psychiatry 1994; 4416-8.
90. Tissot R, Constantinidis J, Richard J. In: Tissot R, Constantinidis J, Richard J, (ed). La maladie de Pick. Paris: Masson; 1975. p. 57-91.
91. Tranel D, Bechara A, Denburg NL. Asymmetric functional roles of right and left ventromedial prefrontal cortices in social conduct, decision-making, and emotional processing. Cortex 2002; 38: 589-612.
92. Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004; 36: 377-81.
93. Yang Y, Schmitt HP. Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method. Acta Neuropathol (Berl) 2001; 101: 256-70.
94. Zappoli R. Permanent or transitory effects on neurocognitive components of the CNV complex induced by brain dysfunctions, lesions and ablations in humans. Int J Psychophysiol 2003; 48: 189-220.